Pharmacovigilance Training: More Than a “Necessary Evil”?

For many pharmaceutical and biotech organisations, pharmacovigilance training is still treated as a necessary evil. It is delivered, completed, documented and filed away. Another compliance requirement ticked off.

But this raises an important question.

How confident are you that your teams could apply that training in a real situation?

If a member of your field force receives an adverse event during a conversation, would they recognise it immediately and report it correctly?

If asked during an inspection, could your non-PV staff clearly explain their responsibilities and the timelines they are expected to meet?

In many organisations, the framework is there. Training records exist, attendance is tracked, and materials align with regulatory requirements. Yet the practical understanding behind it can be inconsistent.

This is where the perception of PV training as a “necessary evil” begins.

When training is overly focused on regulations rather than real-world application, it becomes something teams complete rather than something they use. Over time, this can lead to gaps in knowledge, uncertainty in decision-making, and increased risk during inspections.

At PharmaGuard, we see PV training differently. When designed around real scenarios and aligned with how a company actually operates, it becomes a practical tool that supports confident decision-making, consistent processes, and ultimately, patient safety.

Why Pharmacovigilance Training Matters More Than Ever

Regulatory expectations around pharmacovigilance training are well established. Under EU Good Pharmacovigilance Practice (GVP), marketing authorisation holders are required to maintain a robust PV system supported by appropriately trained staff, role-specific learning and documented competence.

Most organisations are aware of these requirements.

The more difficult question is whether they can consistently demonstrate them.

Inspection findings continue to highlight gaps in training programmes, including incomplete documentation, limited evidence of understanding and training that is not clearly linked to real responsibilities. In many cases, the issue is not the absence of training, but the inability to show that it is effective.

If your organisation were inspected tomorrow, what evidence would you provide to show that your teams truly understand their PV obligations?

This is where pharmacovigilance training moves beyond a procedural requirement. It becomes a key part of how an organisation demonstrates control over its safety system.

Effective training directly supports:

Inspection readiness, with clear evidence of competence and fewer critical or major findings

Consistent adverse event reporting and case handling across affiliates, partners and third parties

Stronger governance across activities such as promotional review, medical information and risk minimisation

When training is aligned with real roles and responsibilities, it gives organisations something more than compliance documentation. It provides confidence that processes will be followed correctly under pressure, and that safety responsibilities are understood across the business.

Why PV Training Is Often Seen as a “Necessary Evil”

Despite its importance, pharmacovigilance training often struggles to gain real engagement across the wider business. For many non-PV functions, it is something to complete rather than something to rely on.

This perception usually comes from experience.

Training can feel disconnected from day-to-day responsibilities, particularly for teams in commercial, medical or regulatory roles. Content is often built around regulatory text rather than practical situations, making it difficult to translate into real decisions.

If your teams were asked to apply their PV training in a live scenario, would they feel confident, or would they need to refer back to slides or procedures?

In many organisations, training still takes the form of an annual exercise. Sessions are delivered, attendance is recorded, and completion is tracked. But opportunities to test understanding, ask questions or explore real-world scenarios can be limited.

This creates a gap between knowledge and application.

Training is completed, but not always retained

Responsibilities are defined, but not always fully understood

Processes are documented, but not always followed with confidence

Over time, this is what leads to the perception of PV training as a “necessary evil”. Not because it lacks importance, but because it is not clearly connected to the situations people face in their roles.

This is also where risk begins to build.

Uncertainty around recognising adverse events, hesitation in reporting, or inconsistent handling of safety information are all common themes identified during audits and inspections. In many cases, these issues can be traced back to training that did not fully translate into practice.

PharmaGuard’s Approach: Making Compliance Practical

PharmaGuard was founded on a simple principle: pharmacovigilance should be clear, practical and fully integrated into how a business operates.

For many organisations, PV can feel like a separate function, only revisited during audits, inspections or when issues arise. Training often reflects this, sitting alongside the business rather than being embedded within it.

The result is a disconnect between what is taught and what actually happens in practice.

If your training content does not reflect how your PV system operates day to day, how confident can you be that it will stand up during an inspection?

PharmaGuard’s approach is designed to close that gap.

Clarity over complexity Regulatory requirements are translated into plain language, practical guidance and role-specific expectations. This helps teams understand not just what they need to do, but how it applies in real situations.

Aligned to your PV system Training is built around the organisation’s PSMF, procedures, QPPV responsibilities and quality metrics. This ensures that what staff are taught reflects what inspectors will expect to see.

Grounded in real inspection experience Because PharmaGuard supports organisations with QPPV services, audits, PSMF maintenance and promotional review, training is shaped by common findings, known risk areas and real inspection scenarios.

This means training is not treated as a standalone requirement. It becomes part of a wider, connected pharmacovigilance system where people understand their role, processes are applied consistently, and expectations are clear across the organisation.

Tailored, Practical PV Training – Not Off-the-Shelf Slides

No two pharmacovigilance systems are identical. Organisational structures, product portfolios, partner networks and risk profiles all influence how safety responsibilities are managed in practice.

Yet training is often delivered in a standardised format.

Generic content can meet basic requirements, but it rarely reflects the specific challenges teams face within their own organisation. Over time, this can lead to training that is completed, but not fully applied.

If your current PV training were reviewed in detail, how closely would it reflect your actual procedures, risks and day-to-day activities?

PharmaGuard takes a different approach. Training is designed around the organisation itself, ensuring that content is directly relevant to how the PV system operates in practice.

This typically includes:

Role-specific content Tailored modules for PV teams, senior leadership, QPPV deputies, commercial staff, distributors and third-party providers, ensuring each group understands its specific responsibilities.

Organisation-specific scenarios Realistic case studies based on audit findings, deviation trends and internal procedures, helping teams apply learning in situations they are likely to encounter.

Engaging, practical formats Workshops, interactive sessions and open discussion points that encourage participation, rather than passive completion of slide-based training.

Robust documentation and follow-up Training matrices, attendance records and knowledge checks that not only meet regulatory expectations, but provide clear evidence of competence.

This approach helps ensure that training is not only delivered, but understood, applied and demonstrable during inspections.

Business Impact: From Risk Reduction to Stronger Culture

When pharmacovigilance training is aligned with real responsibilities and embedded into the wider system, the impact extends beyond compliance.

It addresses many of the underlying issues that lead to inspection findings and operational inconsistencies.

For organisations where training has traditionally been treated as a periodic requirement, the difference can be significant.

Reduced inspection risk Fewer findings linked to knowledge gaps, clearer evidence of competence and stronger alignment between procedures and day-to-day activities.

More consistent processes across teams and partners Improved handling of adverse events, clearer communication between functions and greater confidence when working with third parties.

Greater accountability at all levels Staff understand their responsibilities and are more confident applying them, reducing reliance on escalation for routine decisions.

A more embedded safety culture Pharmacovigilance becomes part of everyday thinking, rather than something revisited only during training cycles or inspections.

Increased organisational confidence Leaders have greater visibility and assurance that their PV system is operating as intended, not just documented as compliant.

In practice, this is where pharmacovigilance training shifts from being a perceived burden to a structured, reliable part of how the organisation manages risk and protects patients.

How PharmaGuard Can Support Your PV Training

If your current pharmacovigilance training feels more like a compliance exercise than a practical tool, it may be time to take a closer look at how it supports your wider PV system.

PharmaGuard works with organisations to review, design and deliver training that reflects real responsibilities, aligns with regulatory expectations and stands up to inspection.

This can include:

Reviewing existing training programmes to identify gaps in content, structure and evidence of effectiveness

Designing role-specific training aligned to your PSMF, procedures and organisational structure

Supporting inspection readiness through clear documentation, knowledge checks and training records

Delivering practical, scenario-based sessions that help teams apply PV requirements with confidence

Whether you are preparing for an upcoming inspection or looking to strengthen your overall PV framework, the focus remains the same: making pharmacovigilance training clear, relevant and demonstrable.

If you would like an objective view of how your current training would stand up under inspection, we are happy to provide an initial review and practical recommendations.

👉 Get in touch to explore how our pharmacovigilance and compliance expertise can strengthen your next move.